Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 979,280 | 837,170 | 740,350 | 576,000 | 459,000 |
| Depreciation Amortization | 322,310 | 315,960 | 246,730 | 187,000 | 128,000 |
| Other Working Capital | -65,790 | 17,860 | -192,930 | -100,000 | -173,000 |
| Other Operating Activity | 219,100 | 96,370 | 144,480 | 23,000 | 99,000 |
| Operating Cash Flow | $1,454,900 | $1,267,360 | $938,630 | $686,000 | $513,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -612,050 | -500,830 | -352,340 | -549,000 | -491,000 |
| Net Acquisitions | -58,450 | 0 | 1,520 | -56,000 | 0 |
| Other Investing Activity | -149,630 | 166,670 | -1,680 | -11,000 | 0 |
| Investing Cash Flow | $-820,130 | $-334,160 | $-352,500 | $-616,000 | $-491,000 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -266,190 | -248,490 | -189,430 | -162,000 | -108,000 |
| Other Financing Activity | -474,450 | -330,330 | -175,410 | -52,000 | -4,000 |
| Financing Cash Flow | $-740,640 | $-578,820 | $-364,840 | $-214,000 | $-112,000 |
| Exchange Rate Effect | 25,710 | 0 | -2,590 | -4,000 | -3,000 |
| Beginning Cash Position | 494,820 | 140,440 | 188,060 | 321,000 | 365,000 |
| End Cash Position | 414,660 | 494,820 | 406,750 | 173,000 | 272,000 |
| Net Cash Flow | $-80,160 | $354,370 | $218,690 | $-148,000 | $-93,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,454,900 | 1,267,360 | 938,630 | 686,000 | 513,000 |
| Free Cash Flow | 1,454,900 | 1,267,360 | 938,630 | 686,000 | 513,000 |